PCOS (Polycystic Ovarian Syndrome) Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Health Related. Basic parameters: 18 years — 40 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prospective Cohort Study for PCOS Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)
Overview
The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
Detailed description
Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition characterized by chronic anovulation and excess ovarian activity.
Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. The current project plans to recruit PCOS participants in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for PCOS prognosis.
Primary outcome measures
- Level of serum FSH (Follicle stimulating hormone) [Time frame: From date of inclusion, assessed by each 12 month, up to 40 years]
- Level of serum LH (Luteinizing hormone) [Time frame: From date of inclusion, assessed by each 12 month, up to 40 years]
- Level of T (Testosterone) [Time frame: From date of inclusion, assessed by each 12 month, up to 40 years]
Secondary outcome measures (2)
- Body Weight [Time frame: From date of inclusion, assessed by each 12 month, up to 40 years]
- Height [Time frame: From date of inclusion, assessed by each 12 month, up to 40 years]
Eligibility criteria
Inclusion criteria
- PCOS patients diagnosed with The Rotterdam diagnostic criteria.
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University — Zhengzhou
Identifiers
NCT: NCT03991507 · RMCZZU-PCOS cohort study